Blog Post

FDA Working to Address 2019 Novel Coronavirus: Product Safety (Part I)

MoFo Life Sciences blog

03 Mar 2020

FDA has been working intensely, mostly behind the scenes both in the United States and abroad, to address a number of important public health issues, including product safety, monitoring supply chain disruptions, and supporting emergency efforts to diagnose and treat the disease. In addition, FDA is addressing safety concerns with its own workforce. In this three-part article, we explain FDA’s efforts in each of these three areas and highlight the impact on different sectors of the healthcare industry impacted by the coronavirus and also FDA’s focused efforts.

Read the full blog post.



Unsolicited e-mails and information sent to Morrison & Foerster will not be considered confidential, may be disclosed to others pursuant to our Privacy Policy, may not receive a response, and do not create an attorney-client relationship with Morrison & Foerster. If you are not already a client of Morrison & Foerster, do not include any confidential information in this message. Also, please note that our attorneys do not seek to practice law in any jurisdiction in which they are not properly authorized to do so.